Nasal Polyposis Clinical Trial
Official title:
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)
This is a randomized, double-blind, placebo-controlled, parallel-group, international, multicenter, Phase 3 study to evaluate the efficacy and safety of repeat dosing of benralizumab 30 mg administered subcutaneously (SC) versus placebo in patients with severe nasal polyposis.
Approximately 275 patients will be randomized to receive benralizumab 30 mg SC or matching placebo. After enrolment, eligible patients will enter a 6-week screening/run in period. Patients who meet eligibility criteria will be randomised 1:1 at Week 0 (Day 0) to receive either placebo or benralizumab 30 mg SC every 4 weeks for the first 3 doses (Weeks 0, 4 and 8) and every 8 weeks thereafter (Weeks 16, 24, 32, 40 and 48). An end of treatment visit will be conducted at Week 56.All patients who complete the 56-week DB treatment period on investigational product (IP) may be eligible to continue into around one year OLE, during which all patients will receive 8 doses of benralizumab 30 mg. Patients in Benra arm during DB period will receive one dummy dose. The last study visit will occur at 8 weeks after the last dose of IP (Week 112/FU). Patients who do not enter OLE, will have their last study visit at Week 56 (EoDB) for follow-up and without administration of IP. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04532736 -
Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis
|
Phase 2 | |
Completed |
NCT02784262 -
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis
|
Phase 2 | |
Completed |
NCT02562924 -
The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery
|
N/A | |
Completed |
NCT00480298 -
Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis
|
Phase 2 | |
Completed |
NCT03358329 -
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)
|
Phase 3 | |
Active, not recruiting |
NCT01906697 -
The Effect of RF Turbinoplasty in Polypoid Change of Middle Turbinates
|
Phase 3 | |
Completed |
NCT03591068 -
Efficacy & Safety of OPN-375 Adults With Bilateral Nasal Polyps Using Nasoendoscopic Video
|
Phase 3 | |
Recruiting |
NCT05056714 -
Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score)
|
||
Completed |
NCT03401229 -
Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis
|
Phase 3 | |
Recruiting |
NCT03979716 -
Smell Exploration in Patients With Nasal Polyposis : Study by Functional Magnetic Resonance Imaging
|
N/A | |
Not yet recruiting |
NCT05131958 -
Nasality Evolution in a Nasal Polyposis Context : Multiparametric Evaluation : Articulatory (Imaging), Aerodynamics, Acoustics and Perception
|
||
Completed |
NCT02291549 -
S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps
|
Phase 3 | |
Completed |
NCT01393340 -
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
|
Phase 2 | |
Completed |
NCT02734849 -
Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
|
Phase 2 |